Effective as of August 31st 2016
Spectrum Medical Ltd and Medtronic Inc. have entered into a strategic and exclusive
relationship for the distribution of Spectrum Medical’s new Quantum Perfusion
Systems. The initial three year term
includes all markets in Europe, Africa, The Middle East, Central Asia, Canada,
Australia and New Zealand.
Following five years of intensive Research
and Development Spectrum Medical will launch in 2017 an exciting new generation
of Extracorporeal Technologies and Integrated Patient Safety Systems designed
specifically for cardiopulmonary bypass and ECMO therapies.
Steve Turner, Spectrum Medical’s CEO stated
that: “Spectrum Medical and Medtronic have enjoyed a proven track record of
working successfully together in the various European markets and have become
synergistic in their vision for the future of global Perfusion Technologies. Spectrum Medical’s partnership with Medtronic
will enable customers worldwide to have greater access to these exciting new